北美结构性心脏市场预测至 2028 年 - 区域分析 - 按产品(封堵器、瓣环成形术环、心脏瓣膜球囊等)、手术(心脏瓣膜狭窄、心脏瓣膜反流和左心耳封堵)和最终用户(医院) 、门诊手术中心和心脏中心)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028


No. of Pages: 133    |    Report Code: BMIRE00028946    |    Category: Life Sciences

North America Structural Heart Market

北美结构心脏市场预计将从2022年的69.675亿美元增长到2028年的112.0147亿美元。预计2022年至2028年复合年增长率为8.2%。

创新结构心脏服务的可用性推动北美结构心脏市场

根据世界卫生组织(WHO)的数据,心血管疾病是全球第二大死亡原因。因此,正在采取各种举措来控制心血管疾病。心脏瓣膜疾病预计是心力衰竭的最常见原因之一。主动脉瓣和二尖瓣的退行性疾病以及三尖瓣功能障碍的疾病在严重的情况下会导致更严重的临床病程。近年来,针对结构性心脏病的微创、外科手术和基于导管的干预措施急剧增加。结构性心脏是一个不断发展的领域,包括心脏瓣膜手术和经导管手术;因此,正在为心脏外科医生和内科医生安排各种培训方案。在过去的十年中,结构性心脏病的发病率不断上升,因此有必要制定正式的培训计划,以确保劳动力具备适当的能力。不同项目的培训结构、长度和范围差异很大。大多数项目提供经导管主动脉瓣置换术 (TAVR) 手术的扎实暴露,同时提供房间隔或室间隔缺损封堵、左心耳封堵和先天性心脏病干预的较少且可变的经验。随着 TAVR、MitraClip 二尖瓣修复系统(雅培血管)和左心耳封堵术 (LAAO) 手术的出现,用于治疗复杂心血管疾病患者的结构性心脏手术数量显着增加。许多组织已经以有组织的形式为结构性心脏计划开发了服务和程序产品,以适应大量患者的涌入。总体而言,SHD 培训令人兴奋、富有挑战性且回报丰厚。随着该领域的发展,SHD 培训的标准化对于确保患者护理的最佳质量变得极其重要。寻找一位导师来帮助解决概述的众多考虑因素可能是成功从培训过渡到实践的最佳资产。

北美结构心脏市场概览

2022 年至 2028 年,北美结构心脏市场预计将以 8.2% 的复合年增长率增长。推动市场增长的关键因素是创新的结构心脏服务和心血管疾病的数量和培训计划。然而,高昂的手术成本以及有关结构心脏装置的严格法规是阻碍市场增长的主要因素。

北美结构心脏市场收入和预测到 2028 年(百万美元)

北美国结构心脏市场细分

北美结构心脏市场细分为产品、程序、最终用户和国家/地区。

根据产品,北美结构性心脏市场分为封堵器、瓣环成形术环、心脏瓣膜球囊等。 2022 年,封堵器细分市场在北美结构性心脏市场中占据最大份额。

根据程序,北美结构性心脏市场分为心脏瓣膜狭窄、心脏瓣膜关闭不全,左心耳关闭。 2022 年,心脏瓣膜狭窄细分市场在北美结构性心脏市场中占据最大份额。

根据最终用户,北美结构性心脏市场分为医院、门诊手术中心等。 2022 年,医院细分市场在北美结构性心脏市场中占据最大份额。

按国家/地区划分,北美结构性心脏市场分为美国、加拿大和墨西哥。 2022 年,美国将主导北美结构心脏市场。

雅培实验室 (Abbott Laboratories)、美敦力 (Medtronic Plc)、波士顿科学公司 (Boston Scientific Corp)、Artivion Inc、Edwards Lifesciences Corp,乐普医疗科技北京有限公司、Braile Biomedica Industry, Commerce and Representations Ltd 和 Micro Interventional Devices Inc 是北美结构心脏市场的一些领先公司。    



North America Structural Heart Strategic Insights

Strategic insights for North America Structural Heart involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/north-america-structural-heart-market-strategic-framework.webp
Get more information on this report

North America Structural Heart Report Scope

Report Attribute Details
Market size in 2022 US$ 6,967.50 Million
Market Size by 2028 US$ 11,201.47 Million
Global CAGR (2022 - 2028) 8.2%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By 产品
  • 封堵器
  • 瓣环成形环
  • 心脏瓣膜球囊
By 手术
  • 心脏瓣膜狭窄
  • 心脏瓣膜反流
  • 左心耳封堵术
By 最终用户
  • 医院
  • 门诊手术中心
  • 心脏中心
Regions and Countries Covered 北美
  • 美国
  • 加拿大
  • 墨西哥
Market leaders and key company profiles
  • Abbott Laboratories
  • Medtronic Plc
  • Boston Scientific Corp
  • Artivion Inc
  • Edwards Lifesciences Corp
  • Lepu Medical Technology Beijing Co Ltd
  • Braile Biomedica Industry, Commerce and Representations Ltd
  • Micro Interventional Devices Inc
  • Get more information on this report

    North America Structural Heart Regional Insights

    The regional scope of North America Structural Heart refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/north-america-structural-heart-market-geography.webp
    Get more information on this report

    The List of Companies - North America Structural Heart Market

    1. Abbott Laboratories 
    2. Medtronic Plc 
    3. Boston Scientific Corp
    4. Artivion Inc
    5. Edwards Lifesciences Corp 
    6. Lepu Medical Technology Beijing Co Ltd 
    7. Braile Biomedica Industry, Commerce and Representations Ltd 
    8. Micro Interventional Devices Inc
    Frequently Asked Questions
    How big is the North America Structural Heart Market?

    The North America Structural Heart Market is valued at US$ 6,967.50 Million in 2022, it is projected to reach US$ 11,201.47 Million by 2028.

    What is the CAGR for North America Structural Heart Market by (2022 - 2028)?

    As per our report North America Structural Heart Market, the market size is valued at US$ 6,967.50 Million in 2022, projecting it to reach US$ 11,201.47 Million by 2028. This translates to a CAGR of approximately 8.2% during the forecast period.

    What segments are covered in this report?

    The North America Structural Heart Market report typically cover these key segments-

  • 产品 (封堵器, 瓣环成形环, 心脏瓣膜球囊)
  • 手术 (心脏瓣膜狭窄, 心脏瓣膜反流, 左心耳封堵术)
  • 最终用户 (医院, 门诊手术中心, 心脏中心)
  • What is the historic period, base year, and forecast period taken for North America Structural Heart Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Structural Heart Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in North America Structural Heart Market?

    The North America Structural Heart Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Abbott Laboratories
  • Medtronic Plc
  • Boston Scientific Corp
  • Artivion Inc
  • Edwards Lifesciences Corp
  • Lepu Medical Technology Beijing Co Ltd
  • Braile Biomedica Industry, Commerce and Representations Ltd
  • Micro Interventional Devices Inc
  • Who should buy this report?

    The North America Structural Heart Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Structural Heart Market value chain can benefit from the information contained in a comprehensive market report.